Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vestergaard

Showing results (51-60 of 520) with videos related to

Pageof 52
Sort By:
Ugeskrift for Laeger|September 6, 2005
[Alcohol consumption and the risk of atrial fibrillation or flutter--secondary publication. A cohort study]Lars Frost, Peter Vestergaard
Ugeskrift for Laeger|October 10, 2009
[Management of serum calcium with cinacelet in parathyroid cancer]Peter Vestergaard, Anne Katrine Sanden
Ugeskrift for Laeger|September 2, 2015
[Medical treatment of osteoporosis in men]Pia A Eiken, Peter Vestergaard
Endocrinology and Metabolism Clinics of North America|July 27, 2019
Calcium Metabolic Disorders in Pregnancy: Primary Hyperparathyroidism, Pregnancy-Induced Osteoporosis, and Vitamin D Deficiency in PregnancyJulius Simoni Leere, Peter Vestergaard
Ugeskrift for Laeger|November 23, 2012
[Medical therapy of osteoporosis in patients with mildly to moderate decreased renal function]Pia A Eiken, Peter Vestergaard
Bone|June 10, 2015
Response to: Bone alkaline phosphatase levels do not necessarily cause hypermineralization per seJakob Starup-Linde, Peter Vestergaard
Ugeskrift for Laeger|February 20, 2008
[Treatment and prevention of osteoporosis in patients with decreased renal function]Peter Vestergaard, Pia A Eiken
Ugeskrift for Laeger|November 23, 2012
[Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover]Peter Vestergaard, Pia A Eiken
European Journal of Endocrinology|August 6, 2015
Management of endocrine disease: Diabetes and osteoporosis: cause for concern?Jakob Starup-Linde, Peter Vestergaard
Best Practice & Research. Clinical Rheumatology|September 26, 2022
Diabetes and osteoporosis - Treating two entities: A challenge or cause for concern?Nicklas H Rasmussen, Peter Vestergaard
Pageof 52

Showing results (51-60 of 520) with videos related to

Sort By:
Pageof 52
Ugeskrift for Laeger|September 6, 2005
[Alcohol consumption and the risk of atrial fibrillation or flutter--secondary publication. A cohort study]Lars Frost, Peter Vestergaard
Ugeskrift for Laeger|October 10, 2009
[Management of serum calcium with cinacelet in parathyroid cancer]Peter Vestergaard, Anne Katrine Sanden
Ugeskrift for Laeger|September 2, 2015
[Medical treatment of osteoporosis in men]Pia A Eiken, Peter Vestergaard
Endocrinology and Metabolism Clinics of North America|July 27, 2019
Calcium Metabolic Disorders in Pregnancy: Primary Hyperparathyroidism, Pregnancy-Induced Osteoporosis, and Vitamin D Deficiency in PregnancyJulius Simoni Leere, Peter Vestergaard
Ugeskrift for Laeger|November 23, 2012
[Medical therapy of osteoporosis in patients with mildly to moderate decreased renal function]Pia A Eiken, Peter Vestergaard
Bone|June 10, 2015
Response to: Bone alkaline phosphatase levels do not necessarily cause hypermineralization per seJakob Starup-Linde, Peter Vestergaard
Ugeskrift for Laeger|February 20, 2008
[Treatment and prevention of osteoporosis in patients with decreased renal function]Peter Vestergaard, Pia A Eiken
Ugeskrift for Laeger|November 23, 2012
[Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover]Peter Vestergaard, Pia A Eiken
European Journal of Endocrinology|August 6, 2015
Management of endocrine disease: Diabetes and osteoporosis: cause for concern?Jakob Starup-Linde, Peter Vestergaard
Best Practice & Research. Clinical Rheumatology|September 26, 2022
Diabetes and osteoporosis - Treating two entities: A challenge or cause for concern?Nicklas H Rasmussen, Peter Vestergaard
Pageof 52